In May 2024, Members of the Tuberculosis (TB) Vaccine Accelerator Council requested the WHO Secretariat to establish working groups to accelerate the achievement of goals aligned to its mission.

The Finance and Access Working Group (F&A) was established in February 2025 to promote timely and equitable global access to affordably priced new TB vaccines. Since TB primarily impacts low- and middle-income countries and has limited market potential in high-income regions, a strategic approach to market shaping, access and financing is essential. The working group will therefore coordinate efforts across governments, partners, financing institutions, private sector, and civil society to propose strategic partnerships, financing and procurement mechanisms, and market access solutions, with a particular focus on speeding up vaccine availability and access for high TB-burden countries.